Electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions

References

• Abidi, S., Mian, I., Garcia-Ortega, I., Lecomte, T., Raedler, T., Jackson, K., Jackson, K., Pringsheim, T., & Addington, D. (2017). Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 62(9), 635–647. doi:10.1177/0706743717720197
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Association.
   Google Scholar
• Baeza, I., Flamarique, I., Garrido, J. M., Horga, G., Pons, A., Bernardo, M., Morer, A., Lázaro, M. L., & Castro-Fornieles, J. (2010). Clinical experience using electroconvulsive therapy in adolescents with schizophrenia spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 20(3), 205–209. doi:10.1089/cap.2009.0066
   PubMed Web of Science ®Google Scholar
• Ballon, J. S., Ashfaq, H., & Noordsy, D. L. (2018). Clozapine titration for people in early psychosis: A chart review and treatment guideline. Journal of Clinical Psychopharmacology, 38(3), 234–238. doi:10.1097/JCP.0000000000000860
   PubMed Web of Science ®Google Scholar
• Carandang, C., Robbins, D., Mullany, E., Yazbek, M., & Minot, S. (2007). Lamotrigine in adolescent mood disorders: a retrospective chart review. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'enfant Et De L'adolescent, 16(1), 1–8.
   PubMedGoogle Scholar
• Cesková, E., Prikryl, R., Kaspárek, T., & Ondrusová, M. (2005). Psychopathology and treatment responsiveness of patients with first-episode schizophrenia. Neuropsychiatric Disease and Treatment, 1(2), 179–185. doi:10.2147/nedt.1.2.179.61045
   PubMedGoogle Scholar
• Consoli, A., Boulicot, V., Cornic, F., Fossati, P., Barbeau, M., & Cohen, D. (2009). Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia. European Child & Adolescent Psychiatry, 18(4), 250–254. doi:10.1007/s00787-008-0724-6
   PubMed Web of Science ®Google Scholar
• Døssing, E., & Pagsberg, A. K. (2021). Electroconvulsive therapy in children and adolescents: A systematic review of current literature and guidelines. The Journal of ECT, 37(3), 158–170. doi:10.1097/YCT.0000000000000761
   PubMed Web of Science ®Google Scholar
• Fink, M. (2014). What was learned: Studies by the consortium for research in ECT (CORE) 1997–2011. Acta Psychiatrica Scandinavica, 129(6), 417–426. doi:10.1111/acps.12251
   PubMed Web of Science ®Google Scholar
• Flamarique, I., Castro-Fornieles, J., Garrido, J. M., de la Serna, E., Pons, A., Bernardo, M., & Baeza, I. (2012). Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: Is it a safe and effective combination? Journal of Clinical Psychopharmacology, 32(6), 756–766. doi:10.1097/JCP.0b013e318270e2c7
   PubMed Web of Science ®Google Scholar
• Ghaziuddin, N., Kutcher, S. P., Knapp, P., Bernet, W., Arnold, V., Beitchman, J., Benson, R. S., Bukstein, O., Kinlan, J., McClellan, J., Rue, D., Shaw, J. A., Stock, S., & Kroeger Ptakowski, K., AACAP (2004). Practice parameter for use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43(12), 1521–1539. doi:10.1097/01.chi.0000142280.87429.68
   PubMed Web of Science ®Google Scholar
• Ghaziuddin, N., Shamseddeen, W., Gettys, G., & Ghaziuddin, M. (2020). Electroconvulsive therapy for the treatment of severe mood disorders during adolescence: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 30(4), 235–243. doi:10.1089/cap.2019.0054
   PubMed Web of Science ®Google Scholar
• Grover, S., & Avasthi, A. (2019). Clinical practice guidelines for the management of schizophrenia in children and adolescents. Indian Journal of Psychiatry, 61(Suppl 2), 277–293. doi:10.4103/psychiatry.IndianJPsychiatry_556_18
   PubMedGoogle Scholar
• Grover, S., Hazari, N., Chakrabarti, S., & Avasthi, A. (2015). Delay in initiation of clozapine: A retrospective study from a tertiary care hospital in North India. Psychiatry Research, 226(1), 181–185. doi:10.1016/j.psychres.2014.12.046
   PubMed Web of Science ®Google Scholar
• Grover, S., Raju, V., Chakrabarti, S., Sharma, A., Shah, R., & Avasthi, A. (2021). Use of electroconvulsive therapy in adolescents: A retrospective study. Indian Journal of Psychological Medicine, 43(2), 119–124. doi:10.1177/0253717620956730
   PubMedGoogle Scholar
• Joo, S. W., & Kim, H. W. (2018). Treatment of children and adolescents with attention deficit hyperactivity disorder and/or Tourette’s disorder with clonidine extended release. Psychiatry İnvestigation, 15(1), 90–93. doi:10.4306/pi.2018.15.1.90
   PubMed Web of Science ®Google Scholar
• Juárez-Treviño, M., Esquivel, A. C., Isida, L. M. L., Delgado, D. Á G., de la, O. C. M. E., Ocañas, L. G., & Sepúlveda, R. S. (2019). Clozapine in the treatment of aggression in conduct disorder in children and adolescents: A randomized, double-blind, controlled trial. Clinical Psychopharmacology and Neuroscience : The Official Scientific Journal of the Korean College of Neuropsychopharmacology, 17(1), 43–53. doi:10.9758/cpn.2019.17.1.43
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. doi:10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Kim, H. S., Kim, S. H., Lee, N. Y., Youn, T., Lee, J. H., Chung, S., Kim, Y. S., & Chung, I. W. (2017). Effectiveness of electroconvulsive therapy augmentation on clozapine-resistant schizophrenia. Psychiatry İnvestigation, 14(1), 58–62. doi:10.4306/pi.2017.14.1.58
   PubMed Web of Science ®Google Scholar
• Kim, Y., Cho, S. C., Shin, M. S., Kim, J. W., Lee, S. H., & Kim, B. N. (2010). Retrospective case series of aripiprazole augmentation in pervasive developmental disorders. Psychiatry İnvestigation, 7(3), 220–223. doi:10.4306/pi.2010.7.3.220
   PubMed Web of Science ®Google Scholar
• Kim, Y., Kim, B. N., Cho, S. C., Kim, J. W., & Shin, M. S. (2008). Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: A retrospective study in Korean children and adolescents. Human Psychopharmacology, 23(8), 715–722. doi:10.1002/hup.982
   PubMed Web of Science ®Google Scholar
• Komaryk, A., Elbe, D., & Burgess, L. (2021). Retrospective review of clozapine use in children and adolescents. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'enfant Et De L'adolescent, 30(1), 36–48.
   PubMed Web of Science ®Google Scholar
• Krause, M., Zhu, Y., Huhn, M., Schneider-Thoma, J., Bighelli, I., Chaimani, A., & Leucht, S. (2018). Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 28(6), 659–674. doi:10.1016/j.euroneuro.2018.03.008
   PubMed Web of Science ®Google Scholar
• Lally, J., Tully, J., Robertson, D., Stubbs, B., Gaughran, F., & MacCabe, J. H. (2016). Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis. Schizophrenia Research, 171(1–3), 215–224. doi:10.1016/j.schres.2016.01.024
   PubMed Web of Science ®Google Scholar
• Leucht, S., Samara, M., Heres, S., & Davis, J. M. (2016). Dose equivalents for antipsychotic drugs: The DDD method. Schizophrenia Bulletin, 42 (Suppl 1), S90–S94. doi:10.1093/schbul/sbv167
   PubMedGoogle Scholar
• Lieberman, J. A., Tollefson, G., Tohen, M., Green, A. I., Gur, R. E., Kahn, R., McEvoy, J., Perkins, D., Sharma, T., Zipursky, R., Wei, H., & Hamer, R. M, HGDH Study Group. (2003). Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol. The American Journal of Psychiatry, 160(8), 1396–1404. doi:10.1176/appi.ajp.160.8.1396
   PubMed Web of Science ®Google Scholar
• Ma, Y., Rosenheck, R., Fan, N., & He, H. (2019). Rates and patient characteristics of electroconvulsive therapy in China and comparisons with the United States. The Journal of ECT, 35(4), 251–257. doi:10.1097/YCT.0000000000000589
   PubMed Web of Science ®Google Scholar
• Maley, C. T., Becker, J. E., & Shultz, E. K. B. (2019). Electroconvulsive therapy and other neuromodulation techniques for the treatment of psychosis. Child and Adolescent Psychiatric Clinics of North America, 28(1), 91–100. doi:10.1016/j.chc.2018.07.004
   PubMed Web of Science ®Google Scholar
• Mané, A., Baeza, I., Morer, A., Lázaro, M. L., & Bernardo, M. (2005). Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia. Journal of Child and Adolescent Psychopharmacology, 15(6), 844–845. doi:10.1089/cap.2005.15.844
   PubMed Web of Science ®Google Scholar
• Masoudzadeh, A., & Khalilian, A. R. (2007). Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pakistan Journal of Biological Sciences : PJBS, 10(23), 4287–4290. doi:10.3923/pjbs.2007.4287.4290
   PubMedGoogle Scholar
• McClellan, J., & Stock, S., American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). (2013). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 52(9), 976–990. doi:10.1016/j.jaac.2013.02.008
   PubMed Web of Science ®Google Scholar
• Mitchell, S., Hassan, E., & Ghaziuddin, N. (2018). A follow-up study of electroconvulsive therapy in children and adolescents. The Journal of ECT, 34(1), 40–44. doi:10.1097/YCT.0000000000000452
   PubMed Web of Science ®Google Scholar
• Petrides, G., Malur, C., Braga, R. J., Bailine, S. H., Schooler, N. R., Malhotra, A. K., Kane, J. M., Sanghani, S., Goldberg, T. E., John, M., & Mendelowitz, A. (2015). Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: A prospective, randomized study. The American Journal of Psychiatry, 172(1), 52–58. doi:10.1176/appi.ajp.2014.13060787
   PubMed Web of Science ®Google Scholar
• Pierson, M. D., Mickey, B. J., Gilley, L. B., & Weeks, H. R. III (2021). Outcomes of youth treated with electroconvulsive therapy: A retrospective cohort study. J Clin Psychiatry, 82, 19m13164.
   PubMed Web of Science ®Google Scholar
• Rachamallu, V., Elberson, B. W., Vutam, E., & Aligeti, M. (2019). Off-label use of clozapine in children and adolescents-A literature review. American Journal of Therapeutics, 26(3), e406–e416. doi:10.1097/MJT.0000000000000894
   PubMed Web of Science ®Google Scholar
• Rey, J. M., & Walter, G. (1997). Half a century of ECT use in young people. The American Journal of Psychiatry, 154(5), 595–602. doi:10.1176/ajp.154.5.595
   PubMed Web of Science ®Google Scholar
• Schneider, C., Papachristou, E., Wimberley, T., Gasse, C., Dima, D., MacCabe, J. H., Mortensen, P. B., & Frangou, S. (2015). Clozapine use in childhood and adolescent schizophrenia: A nationwide population-based study. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 25(6), 857–863. doi:10.1016/j.euroneuro.2015.02.003
   PubMed Web of Science ®Google Scholar
• Shafer, A., & Dazzi, F. (2019). Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure. Journal of Psychiatric Research, 115, 113–120. doi:10.1016/j.jpsychires.2019.05.008
   PubMed Web of Science ®Google Scholar
• Steinauer, L. M., Leung, J. G., Burkey, B. W., McGrane, I. R., Letts, V., Goren, J. L., Hoeft, D. M., Mullen, S., Maroney, M., Schak, K. M., & Vande Voort, J. L. (2018). A retrospective multicenter evaluation of clozapine use in pediatric patients admitted for acute psychiatric hospitalization. Journal of Child and Adolescent Psychopharmacology, 28(9), 615–619. doi:10.1089/cap.2018.0036
   PubMed Web of Science ®Google Scholar
• Trinczek, E., Heinzel-Gutenbrunner, M., Haberhausen, M., & Bachmann, C. J. (2016). Time to initiation of clozapine treatment in children and adolescents with early-onset schizophrenia. Pharmacopsychiatry, 49(6), 254–259. doi:10.1055/s-0042-116947
   PubMed Web of Science ®Google Scholar
• Wagner, E., McMahon, L., Falkai, P., Hasan, A., & Siskind, D. (2020). Impact of smoking behavior on clozapine blood levels – A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 142(6), 456–466. doi:10.1111/acps.13228
   PubMed Web of Science ®Google Scholar
• Wang, G., Zheng, W., Li, X. B., Wang, S. B., Cai, D. B., Yang, X. H., Ungvari, G. S., Xiang, Y. T., & Correll, C. U. (2018a). ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. Journal of Psychiatric Research, 105, 23–32. doi:10.1016/j.jpsychires.2018.08.002
   PubMed Web of Science ®Google Scholar
• Wang, S., Yang, C., Jia, J., Zhou, Y., & Zheng, Y. (2018b). Use of electroconvulsive therapy in adolescents with schizophrenia in China. Child and Adolescent Psychiatry and Mental Health, 12, 49. doi:10.1186/s13034-018-0254-z
   PubMed Web of Science ®Google Scholar
• Wang, Z. M., Zhu, H., Pan, Y. L., Chiu, H. F., Correll, C. U., Ungvari, G. S., Lai, K. Y., Cao, X. L., Li, Y., Zhong, B. L., Zhang, X. Y., & Xiang, Y. T. (2015). Electroconvulsive therapy and its association with demographic and clinical characteristics in Chinese psychiatric patients. The Journal of ECT, 31(2), 114–118. doi:10.1097/YCT.0000000000000181
   PubMed Web of Science ®Google Scholar
• Whitlock, K., Smith, N., Poulsen, R. J., & Coffey, B. J. (2020). Treatment-resistant depression in an adolescent treated with clozapine: Weighing the options in a young suicidal patient. Journal of Child and Adolescent Psychopharmacology, 30(5), 342–344. doi:10.1089/cap.2020.29184.bjc
   PubMed Web of Science ®Google Scholar